AGA
AZN icon

Accuvest Global Advisors’s AstraZeneca AZN Stock Holding History

Accuvest Global Advisors’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$749K Buy
+4,006
New +$753K 0.64% 32
2025
Q4 		– Sell
-1,473
Closed -$226K – 79
2025
Q3 		$226K Hold
1,473
– – 0.14% 69
2025
Q2 		$206K Buy
+1,473
New +$206K 0.13% 75

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Accuvest Global Advisors's AZN Position: Q2 2026 in Review

Accuvest Global Advisors opened a new position in AstraZeneca (AZN) in Q2 2026: 4,006 shares worth $749K. The stake represents 0.64% of the portfolio and ranks #32 among its holdings. This is a return to the name: Accuvest Global Advisors previously reported a position in AZN as recently as Q3 2025.

Accuvest Global Advisors first reported a position in AZN in Q2 2025 and has held it in 3 quarters since. 1,503 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Accuvest Global Advisors held 4,006 shares of AstraZeneca worth $749K as of Q2 2026.
  • AstraZeneca was a new Accuvest Global Advisors position in Q2 2026.
  • AstraZeneca made up 0.64% of Accuvest Global Advisors's portfolio in Q2 2026, its #32 holding.
  • Accuvest Global Advisors first reported a position in AstraZeneca in Q2 2025 and has held it in 3 quarters since.
  • 1,503 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Accuvest Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.